Latest Articles
About This Stock
More About This Stock
Read
Read
Read
ARWR Files For Regulatory Permission To Begin Phase 1 Trial Of RNAi; TPIV Announces Phase II Clinical Trials With VGTI Florida
Article By:
BioMedReports
Wednesday, November 19, 2014 3:29 AM EDT
ARWR today announced that it recently filed an application for approval to begin a Phase 1 clinical trial of its RNAi-based therapeutic candidate.TPIV. is pleased to announce a new collaborative research agreement with The Vaccine & Gene Therapy Institute of Florida.
Small Cap Best And Worst Report
Article By:
E.B. Capital Markets
Thursday, November 13, 2014 9:05 AM EDT
The average small cap score is 54.59, above the four week moving average score of 53.22. The average small cap is trading -27.26% below its 52 week high, 0.86% above its 200 dma, and has 9.05 days to cover held short.
Small Cap Best And Worst Report
Article By:
E.B. Capital Markets
Thursday, October 16, 2014 8:48 AM EDT
The average small cap score is 46.22 this week, below the four week moving average score of 48.59. The average small cap is trading -32.93% below its 52 week high, -10.40% below its 200 dma, and has 10.50 days to cover held short. Short interest is near historically actionable levels.